PHM7 Stock Overview
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 2/6 |
Dividends | 6/6 |
Rewards
Risk Analysis
Altria Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$54.55 |
52 Week High | US$54.57 |
52 Week Low | US$36.10 |
Beta | 0.67 |
11 Month Change | 18.21% |
3 Month Change | 16.83% |
1 Year Change | 44.16% |
33 Year Change | 42.06% |
5 Year Change | 21.03% |
Change since IPO | 4.70% |
Recent News & Updates
Recent updates
Shareholder Returns
PHM7 | DE Tobacco | DE Market | |
---|---|---|---|
7D | 2.8% | 4.1% | -0.02% |
1Y | 44.2% | 19.8% | 8.2% |
Return vs Industry: PHM7 exceeded the German Tobacco industry which returned 18.2% over the past year.
Return vs Market: PHM7 exceeded the German Market which returned 7.4% over the past year.
Price Volatility
PHM7 volatility | |
---|---|
PHM7 Average Weekly Movement | 3.0% |
Tobacco Industry Average Movement | 2.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHM7 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PHM7's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
PHM7 fundamental statistics | |
---|---|
Market cap | €91.35b |
Earnings (TTM) | €9.87b |
Revenue (TTM) | €19.59b |
9.3x
P/E Ratio4.7x
P/S RatioIs PHM7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHM7 income statement (TTM) | |
---|---|
Revenue | US$20.36b |
Cost of Revenue | US$6.16b |
Gross Profit | US$14.20b |
Other Expenses | US$3.94b |
Earnings | US$10.26b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.05 |
Gross Margin | 69.76% |
Net Profit Margin | 50.39% |
Debt/Equity Ratio | -736.0% |
How did PHM7 perform over the long term?
See historical performance and comparison